Advertisement

Topics

Latest Biotechnology Business NewsRSS

22:15 EDT 19th September 2017 | BioPortfolio

Boehringer Ingelheim Partnering Deals and Alliances 2010 to 2017 [Report Updated: 01092017] Prices from USD $1495

The Partnering Deals and Alliance since 2010 report provides an indepth insight into the partnering activity of one of the world's leading life sciences companies.On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CDRom version purchased, t...

Rexahn Pharmaceuticals Inc RNN Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 22082017] Prices from USD $250

SummaryRexahn Pharmaceuticals Inc Rexahn Pharmaceuticals, formerly Corporate Road Show.com Inc is a clinical stage biopharmaceutical company that offers discovery, development and commercialization of therapeutics for the treatment of cancer. The company develops anticancer drug candidates which include Archexin that is intended for the treatment of pancreatic cancer. It develops RX3117 used for t...

Global Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 20102017 [Report Updated: 01092017] Prices from USD $1995

The Global Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 20102017 report provides comprehensive understanding and unprecedented access to the royalty financing agreements entered into by the worlds leading biopharma companies. The report provides a detailed understanding and analysis of how and why companies enter business, royalty financing agreements. The f...

Adhesives Market Global Opportunity Analysis And Industry Forecasts To 2022 [Report Updated: 18082017] Prices from USD $4175

According to this latest publication from Meticulous Research, the global adhesives market will grow at a CAGR of 4.5% during the forecast period to reach USD 53,503.0 million by 2022, driven by growing demand for consumer goods with rising urbanization improving lifestyle; rising demands for hot melts adhesives; and growing automotive industry with rising demand for lightweight and low carbon em...

Oregon Health Science University Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23082017] Prices from USD $250

SummaryOregon Health Science University OHSU, a subsidiary of Oregon State University is an academic health center that provides medical education, research, patient care and community services. The center's educational institute offers undergraduate and graduate courses in anesthesiology, dermatology, neurology, psychiatry, periodontology and nursing. It grants doctoral degrees in medicine, dent...

Telix Pharmaceuticals and CellSight Technologies Conclude Collaboration and License Agreement for VisAcT ImmunoPET Technology

MELBOURNE, Australia and SAN FRANCISCO, Sept. 19, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (Telix, the Company) is pleased to announce the conclusion of a collaboration and licensing agreement with CellSight Technologies, Inc. (CellSight) for the VisAcT immunoPET imaging technology (VisAcT). The VisAcT technology enables visualization of the localization and migration of immune ...

Vimta Labs Ltd VIMTALABS Financial and Strategic SWOT Analysis Review [Report Updated: 06092017] Prices from USD $125

Vimta Labs Ltd VIMTALABS Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment y...

Lung Biotechnology PBC Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 22082017] Prices from USD $250

SummaryLung Biotechnology PBC LBI, formerly Lung Biotechnology Inc, is a subsidiary of United Therapeutics Corp, is a biotechnology company that develops and commercializes new therapies for the treatment of PAH and other fatal lung diseases. The company's products comprise Adcirca and Tyvaso. It develops and markets tadalafil tablets, which is an oral medication for the treatment of pulmonary art...

#jobs #lifescience MICROBIOLOGY RESEARCH FELLOWSHIP

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: MICROBIOLOGY RESEARCH FELLOWSHIP .  As part of the Horizon 2020 R&D project “Metafluidics. Advanced toolbox for rapid and cost-effective functional metagenomic screening – microbiology meets microfluidics”, topic Biotec-6-2015, … Continue reading ...

#jobs #lifescience BIOINFORMATICIAN RESEARCH FELLOWSHIP

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: BIOINFORMATICIAN RESEARCH FELLOWSHIP .  As part of the Horizon 2020 R&D project “Metafluidics. Advanced toolbox for rapid and cost-effective functional metagenomic screening – microbiology meets microfluidics”, topic Biotec-6-2015, … Continue read...

Emerging companies clock pace of innovation

Mark HamstraA panel of start-up companies — UnaliWear, Chrono Therapeutics, BraceUnder, Sleep.ai and 23andMe — spoke about the white spaces their organizations targeted and the solutions they created to fill those voids at a special Health Innovation Summit, hosted by CVS Health in partnership with Drug Store News and Mack Elevation in June. read more

InfaCare Pharmaceutical Corp Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 22082017] Prices from USD $250

SummaryInfaCare Pharmaceutical Corp InfaCare is a pharmaceutical company that develops and commercializes proprietary drugs for the neonatal and pediatric patients. The company's lead product, Stanate is a heme oxygenase inhibitor which is used for the treatment of Hyperbilirubinemia or infantile jaundice. Its product candidate is under development, and also undertakes clinical trial services. Inf...

Seattle Genetics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 13062017] Prices from USD $350

Seattle Genetics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Seattle Genetics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report includes business description, detailed reports on mergers and acquisitions MA, divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken...

H. Lee Moffitt Cancer Center Research Institute Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 24082017] Prices from USD $250

SummaryH Lee Moffitt Cancer Center Research Institute Inc Moffitt is a healthcare service provider that concentrates on the development of early stage translational research aimed at the rapid translation of scientific discoveries to benefit patient care. The center offers medical services such as surgical care, fertility preservation, radiation therapy, interventional radiology, rehabilitation s...

Tarsa Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 24082017] Prices from USD $250

SummaryTarsa Therapeutics Inc Tarsa develops therapies for the treatment and prevention of osteoporosis and other bone related diseases. The company develops TBRIA, an oral formulation of calcitonin, a peptide hormone that inhibits bone resorption, which is used for the treatment of postmenopausal osteoporosis in women at least five years post menopause. The company also offers osteoporosis treatm...

Cerveau Technologies, Inc. Announces Collaboration with Banner Health

Cerveau to provide support for MK-6240 use in clinical and basic research studies Cerveau Technologies Inc. today announced a research collaboration with Banner Health to support various research projects studying the stages of Alzheimer’s disease and other neurodegenerative diseases. These research projects will utilize an investigational imaging ag...

Therapure Biopharma Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 22082017] Prices from USD $250

SummaryTherapure Biopharma Inc Therapure is a biopharmaceutical company that offers research and development services. The company's activities include manufacture, development, purification, and packaging of therapeutic proteins and followon biologics. It operates through its division therapure biomanufacturing, therapure innovations and therapure biologics. Therapure's therapure biomanufacturing...

Herantis Pharma Plc HRTIS Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 22082017] Prices from USD $250

SummaryHerantis Pharma Plc Herantis Pharma is a specialty pharmaceutical company that develops pharmaceutical products for dry eye, Parkinson's disease, and secondary lymphedema. The company offers pipeline products such as CDNF for amyotrophic lateral sclerosis, CDNF for Parkinson's disease, CisUCA emulsion cream for atopic dermatitis, CisUCA eye drops for dry eye, and lymfactin for secondary lym...

SomaLogic Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 22082017] Prices from USD $250

SummarySomaLogic Inc SomaLogic is a life science company that discovers, develops and commercializes life science research tools and clinical diagnostic products. The company's products include SOMAscan assay and SOMAmer reagents. Its SOMAscan reagents is a proteomic platform that combines the properties of antibodies and aptamers, which is used in clinical diagnosis of EDTA plasma, citrate plasma...

Santen Pharmaceutical Co Ltd 4536 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 22082017] Prices from USD $250

SummarySanten Pharmaceutical Co Ltd Santen focuses on the development and manufacture and commercialization of pharmaceutical products and medical devices. The ocmpany specializes in ophthalmological products. Its product portfolio includes prescription ophthalmic products, OTC drugs, antiallergy ophthalmic products, and medical devices such as intraocular lenses, among others. Santen markets its ...

Ionis Pharmaceuticals, Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 01082017] Prices from USD $175

Ionis Pharmaceuticals, Inc. Strategy, SWOT and Corporate Finance ReportSummaryIonis Pharmaceuticals, Inc. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.Key HighlightsIonis Pharmaceut...

Alcresta Therapeutics Receives New Innovative Technology Contract from Vizient, Inc. For RELiZORB® (iMMOBILIZED LIPASE) Cartridge

Alcresta Therapeutics, Inc. announced RELiZORB has received an Innovative Technology contract from Vizient, Inc. the largest member-driven health care performance improvement company in the country. The awarded contract, effective Sept. 1, 2017, was based on a recommendation of RELiZORB by hospital members who serve on one of Vizient’s member-led council...

Gan Lee Pharmaceutical Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 28082017] Prices from USD $250

SummaryGan Lee Pharmaceutical Ltd Gan Lee formerly Beijing Gan Lee Biotechnology Co., Ltd. is a biotechnology company that offers research services. The company research and develops various pharmaceutical products. Its products include insulin glargine injection and insulin lispro injection. Gan Lee develops scientific solutions to improve the life of patients with diabetes and other metaboli...

RAC Gamma Serine/Threonine Protein Kinase Protein Kinase Akt 3 or Protein Kinase B Gamma or RAC PK Gamma or STK 2 or AKT3 or EC 2.7.11.1 Pipeline Review, H2 2017 [Report Updated: 29082017] Prices from USD $3500

RAC Gamma Serine/Threonine Protein Kinase Protein Kinase Akt 3 or Protein Kinase B Gamma or RAC PK Gamma or STK 2 or AKT3 or EC 2.7.11.1 Pipeline Review, H2 2017SummaryRAC Gamma Serine/Threonine Protein Kinase Protein Kinase Akt 3 or Protein Kinase B Gamma or RAC PK Gamma or STK 2 or AKT3 or EC 2.7.11.1 RACgamma serine/threonineprotein kinase is an enzyme encoded by the AKT3 gene. AKT3 regulate ...

Council of Medical Specialty Societies Names Dr. Helen Burstin as New EVP & CEO

The Council of Medical Specialty Societies (CMSS) has selected Helen Burstin, MD, MPH, FACP, to be the organization’s next Executive Vice President (EVP) and Chief Executive Officer (CEO). CMSS and its 43 member societies represent 790,000 U.S. physician members. CMSS member societies collaborate to enhance the quality of care delivered in the U...

Quick Search
Advertisement
 

review and buy Biotechnology Business market research data and corporate reports here